Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy

• Hélène Bonsang-Kitzis,

  Affiliations Department of Surgery, Institut Curie, Paris, France, Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, Paris, France, UMR932 Immunity and Cancer, INSERM, Paris, France

  ⨯
• Léonor Chaltier,

  Affiliation Department of Biostatistic, Institut Curie, Paris, France

  ⨯
• Lisa Belin,

  Affiliation Department of Biostatistic, Institut Curie, Paris, France

  ⨯
• Alexia Savignoni,

  Affiliation Department of Biostatistic, Institut Curie, Paris, France

  ⨯
• Roman Rouzier,

  Affiliation Department of Surgery, Institut Curie, Paris, France

  ⨯
• Marie-Paule Sablin,

  Affiliation Department of Medical Oncology, Institut Curie, Paris, France

  ⨯
• Florence Lerebours,

  Affiliation Department of Medical Oncology, Institut Curie, Paris, France

  ⨯
• François-Clément Bidard,

  Affiliation Department of Medical Oncology, Institut Curie, Paris, France

  ⨯
• Paul Cottu,

  Affiliation Department of Medical Oncology, Institut Curie, Paris, France

  ⨯
• Xavier Sastre-Garau,

  Affiliation Department of Tumor Biology, Institut Curie, Paris, France

  ⨯
• Marick Laé,

  Affiliation Department of Tumor Biology, Institut Curie, Paris, France

  ⨯
• Jean-Yves Pierga,

  Affiliations Department of Medical Oncology, Institut Curie, Paris, France, Paris Descartes University, Paris, France

  ⨯
• Fabien Reyal

  * E-mail: fabien.reyal@curie.fr

  Affiliations Department of Surgery, Institut Curie, Paris, France, Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, Paris, France, UMR932 Immunity and Cancer, INSERM, Paris, France

  ⨯